These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury. Chiha W; Bartlett CA; Petratos S; Fitzgerald M; Harvey AR Exp Neurol; 2020 Apr; 326():113167. PubMed ID: 31904385 [TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration. Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131 [TBL] [Abstract][Full Text] [Related]
24. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Koeberle PD; Wang Y; Schlichter LC Cell Death Differ; 2010 Jan; 17(1):134-44. PubMed ID: 19696788 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Tsai RK; Chang CH; Wang HZ Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391 [TBL] [Abstract][Full Text] [Related]
26. A new and reliable animal model for optic nerve injury. Yan H; Li F; Zhang L Curr Eye Res; 2012 Oct; 37(10):941-8. PubMed ID: 22667465 [TBL] [Abstract][Full Text] [Related]
27. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832 [TBL] [Abstract][Full Text] [Related]
28. Reassembly of Excitable Domains after CNS Axon Regeneration. Marin MA; de Lima S; Gilbert HY; Giger RJ; Benowitz L; Rasband MN J Neurosci; 2016 Aug; 36(35):9148-60. PubMed ID: 27581456 [TBL] [Abstract][Full Text] [Related]
29. Acute Cellular and Functional Changes With a Combinatorial Treatment of Ion Channel Inhibitors Following Spinal Cord Injury. O'Hare Doig RL; Santhakumar S; Fehily B; Raja S; Solomon T; Bartlett CA; Fitzgerald M; Hodgetts SI Front Mol Neurosci; 2020; 13():85. PubMed ID: 32670018 [TBL] [Abstract][Full Text] [Related]
30. Effect of intravitreal injection of bevacizumab on optic nerve head leakage and retinal ganglion cell survival in a mouse model of optic nerve crush. Rappoport D; Morzaev D; Weiss S; Vieyra M; Nicholson JD; Leiba H; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8160-71. PubMed ID: 24168994 [TBL] [Abstract][Full Text] [Related]
31. Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice. Ito Y; Nakamura S; Tanaka H; Tsuruma K; Shimazawa M; Araie M; Hara H CNS Neurosci Ther; 2010 Apr; 16(2):103-14. PubMed ID: 19788586 [TBL] [Abstract][Full Text] [Related]
32. Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study. Saggu SK; Chotaliya HP; Blumbergs PC; Casson RJ BMC Neurosci; 2010 Aug; 11():97. PubMed ID: 20707883 [TBL] [Abstract][Full Text] [Related]
33. Complex I inhibition in the visual pathway induces disorganization of the node of Ranvier. Marella M; Patki G; Matsuno-Yagi A; Yagi T Neurobiol Dis; 2013 Oct; 58():281-8. PubMed ID: 23816754 [TBL] [Abstract][Full Text] [Related]
34. RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome. Grinblat GA; Khan RS; Dine K; Wessel H; Brown L; Shindler KS Invest Ophthalmol Vis Sci; 2018 May; 59(6):2470-2477. PubMed ID: 29847652 [TBL] [Abstract][Full Text] [Related]
35. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells. Hollander A; D'Onofrio PM; Magharious MM; Lysko MD; Koeberle PD Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3973-89. PubMed ID: 22531700 [TBL] [Abstract][Full Text] [Related]
36. Rescuing axons from degeneration does not affect retinal ganglion cell death. de Lima S; Mietto BS; Paula C; Muniz T; Martinez AM; Gardino PF Braz J Med Biol Res; 2016; 49(4):e5106. PubMed ID: 27007653 [TBL] [Abstract][Full Text] [Related]
37. Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage. Hara H; Toriu N; Shimazawa M Cardiovasc Drug Rev; 2004; 22(3):199-214. PubMed ID: 15492768 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of acute axonal degeneration in the optic nerve in vivo. Knöferle J; Koch JC; Ostendorf T; Michel U; Planchamp V; Vutova P; Tönges L; Stadelmann C; Brück W; Bähr M; Lingor P Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6064-9. PubMed ID: 20231460 [TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis. Sühs KW; Fairless R; Williams SK; Heine K; Cavalié A; Diem R J Neuropathol Exp Neurol; 2014 Jun; 73(6):507-18. PubMed ID: 24806299 [TBL] [Abstract][Full Text] [Related]
40. Delayed treatment of secondary degeneration following acute optic nerve transection using a combination of ion channel inhibitors. Yates NJ; Giacci MK; O'Hare Doig RL; Chiha W; Ashworth BE; Kenna J; Bartlett CA; Fitzgerald M Neural Regen Res; 2017 Feb; 12(2):307-316. PubMed ID: 28400815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]